Nicole Kelsey Biography and Net Worth

Insider of Amyris

Nicole Kelsey joined Amyris as General Counsel and Secretary in August 2017. Her areas of expertise range from international M&A to U.S. Securities laws and multi-jurisdictional corporate governance. Prior to joining Amyris, she served as General Counsel and Secretary of Criteo, a global leader in commerce marketing based in Paris, where she built a best-in-class legal department providing commercial, corporate, and compliance services to support the company’s worldwide operations. Previously, Ms. Kelsey was the senior securities lawyer for Medtronic, a global leader in medical technology; she served as head M&A attorney for CIT Group, Inc.; was the general counsel of a private merchant bank; and was the senior corporate attorney for the international conglomerate Vivendi. Before going in-house, Ms. Kelsey practiced with the law firms of White & Case and Willkie, Farr & Gallagher, in Paris and New York. A Fulbright scholar, Ms. Kelsey holds a J.D. from Northwestern Pritzker School of Law and a B.A. in Political Science and International Studies from The Ohio State University, and is admitted to practice law in both New York and Minnesota.

What is Nicole Kelsey's net worth?: The estimated net worth of Nicole Kelsey is at least $0.00 as of June 30th, 2022. Ms. Kelsey owns 63,333 shares of Amyris stock worth more than $0 as of November 4th. This net worth evaluation does not reflect any other assets that Ms. Kelsey may own. Learn More about Nicole Kelsey's net worth.
How do I contact Nicole Kelsey?: The corporate mailing address for Ms. Kelsey and other Amyris executives is 5885 HOLLIS STREET SUITE 100, EMERYVILLE CA, 94608. Amyris can also be reached via phone at (510) 450-0761 and via email at [email protected]. Learn More on Nicole Kelsey's contact information.
Has Nicole Kelsey been buying or selling shares of Amyris?: Nicole Kelsey has not been actively trading shares of Amyris over the course of the past ninety days. Most recently, Nicole Kelsey sold 94,033 shares of the business's stock in a transaction on Thursday, June 30th. The shares were sold at an average price of $1.80, for a transaction totalling $169,259.40. Following the completion of the sale, the insider now directly owns 63,333 shares of the company's stock, valued at $113,999.40. Learn More on Nicole Kelsey's trading history.
Who are Amyris' active insiders?: Amyris' insider roster includes Eduardo Alvarez (COO), Anthony Hughes (CAO), Nicole Kelsey (Insider), Hermanus Kieftenbeld (CFO), Frank Kung (Director), James McCann (Director), and John Melo (CEO). Learn More on Amyris' active insiders.

Nicole Kelsey Insider Trading History at Amyris

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/30/2022	Sell	94,033	$1.80	$169,259.40	63,333
6/2/2022	Sell	8,406	$2.34	$19,670.04	157,366
9/2/2021	Sell	3,483	$14.86	$51,757.38

Nicole Kelsey Buying and Selling Activity at Amyris

Amyris Company Overview

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Today's Range

Now: N/A

50 Day Range

MA: $0.54

$0.05

$1.17

2 Week Range

Now: N/A

Volume

46,746,000 shs

Average Volume

12,593,118 shs

Market Capitalization

$18.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Central banks prepare for America’s Breaking Point

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.